Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Other Equity
Abbott Laboratories
Other Equity Peer Comparison
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Other Equity
$-7.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-14%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Other Equity
$-1.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-12%
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Equity
$50m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-7%
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Other Equity
$-218m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-23%
|
|
Stryker Corp
NYSE:SYK
|
Other Equity
$-416m
|
CAGR 3-Years
29%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Equity
$-31.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
See Also
What is Abbott Laboratories's Other Equity?
Other Equity
-7.8B
USD
Based on the financial report for Dec 31, 2023, Abbott Laboratories's Other Equity amounts to -7.8B USD.
What is Abbott Laboratories's Other Equity growth rate?
Other Equity CAGR 10Y
-14%
Over the last year, the Other Equity growth was 3%. The average annual Other Equity growth rates for Abbott Laboratories have been 4% over the past three years , -1% over the past five years , and -14% over the past ten years .